DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹9,042 Cr | ₹8,030 Cr | ₹7,249 Cr | ₹6,676 Cr | ₹4,964 Cr |
What is the latest Sundry Debtors ratio of DR REDDYS LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹9,042 Cr |
| Mar2024 | ₹8,030 Cr |
| Mar2023 | ₹7,249 Cr |
| Mar2022 | ₹6,676 Cr |
| Mar2021 | ₹4,964 Cr |
How is Sundry Debtors of DR REDDYS LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,042 Cr | 12.61 | |
| Mar2024 | ₹8,030 Cr | 10.78 | |
| Mar2023 | ₹7,249 Cr | 8.57 | |
| Mar2022 | ₹6,676 Cr | 34.49 | |
| Mar2021 | ₹4,964 Cr | - | |
Compare Sundry Debtors of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹106,737.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| MANKIND PHARMA | ₹89,743.8 Cr | 1.5% | -2.8% | -19.5% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -0.1% |
2.5% |
2.5% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses